The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 24, 2026

Filed:

Jul. 17, 2020
Applicants:

2692372 Ontario, Inc., Mississauga, CA;

Dunad Therapeutics Ltd., Great Cambourne, GB;

Inventors:

Patrick T. Gunning, Mississauga, CA;

Ji Sung Park, Milton, CA;

Siawash Ahmar, Toronto, CA;

Aaron D. Cabral, Mississauga, CA;

Gary K.C. Tin, Richmond Hill, CA;

Sana Rasheed, Mississauga, CA;

Ayah Abdeldayem, Mississauga, CA;

David Armstrong, Mississauga, CA;

Geordon A. Frere, Drayton, CA;

Erica J. Quilates, Brampton, CA;

David Alexander Rosa, Toronto, CA;

Olga Gozhina, Ontario, CA;

Jeffrey Alan Omeara, Halton Hills, CA;

Graham Simpson, Great Wymondley, GB;

Vittoria Zoppi, Ontario, CA;

Assignees:

2692372 Ontario, Inc., Mississauga, CA;

Dunad Therapeutics LTD., Cambridge, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 311/29 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 9/48 (2006.01); C07C 311/39 (2006.01); C07D 205/04 (2006.01); C07D 213/30 (2006.01); C07D 213/74 (2006.01); C07D 239/48 (2006.01); C07D 295/096 (2006.01); C07D 305/06 (2006.01); C07D 487/04 (2006.01); C07K 1/107 (2006.01);
U.S. Cl.
CPC ...
C07C 311/29 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 9/4825 (2013.01); C07C 311/39 (2013.01); C07D 205/04 (2013.01); C07D 213/30 (2013.01); C07D 213/74 (2013.01); C07D 239/48 (2013.01); C07D 295/096 (2013.01); C07D 305/06 (2013.01); C07D 487/04 (2013.01); C07K 1/1077 (2013.01);
Abstract

Provided herein are benzenesulfonamide derivatives having Formula (III), pharmaceutical compositions comprising said compounds, and method for using said compounds for disrupting proteins/polypeptides, protein/polypeptide function, and for the treatment of diseases through the disruption of proteins or polypeptides involved in the etiology of the disease. Said compounds comprise fluorinated benzene sulfonamide structures.


Find Patent Forward Citations

Loading…